GOOGL Alphabet | $171.95 +10.2% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024 |
TEAM Atlassian | $179.45 -9.6% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $250.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 4/26/2024 |
CSL Carlisle Companies | $400.56 +4.9% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $412.00 -> $430.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/26/2024 |
CARR Carrier Global | $60.50 +1.2% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $63.00 -> $64.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/26/2024 |
DOV Dover | $180.17 +0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $187.00 -> $197.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/26/2024 |
RMD ResMed | $218.06 +18.9% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $200.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 4/26/2024 |
|
SPGI S&P Global | $415.78 +0.1% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $482.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/26/2024 |
TDOC Teladoc Health | $13.01 -2.4% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $21.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 4/26/2024 |
TPH Tri Pointe Homes | $37.88 +2.9% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $41.00 -> $46.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 4/26/2024 |
WM Waste Management | $210.10 -1.2% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $221.00 -> $228.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 4/26/2024 |
TYL Tyler Technologies | $460.74 +0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $500.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 4/26/2024 |
VRT Vertiv | $93.49 +3.5% | 4/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $96.00 -> $98.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/25/2024 |
CMG Chipotle Mexican Grill | $3,186.97 +2.4% | 4/25/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $2,825.00 -> $3,300.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
CYH Community Health Systems | $3.39 +4.3% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $4.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 4/25/2024 |
HUM Humana | $305.90 -1.8% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $415.00 -> $370.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 4/25/2024 |
META Meta Platforms | $443.29 +0.4% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $585.00 -> $500.00 | N/A | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
ENPH Enphase Energy | $111.93 +3.8% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $134.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024 |
INCY Incyte | $51.68 +1.0% | 4/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $84.00 | Low | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 4/24/2024 |
NBIX Neurocrine Biosciences | $135.99 -1.3% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $200.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
NEP NextEra Energy Partners | $28.93 -0.9% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of NextEra Energy Partners (NYSE:NEP) on 4/24/2024 |
PNR Pentair | $79.96 +1.0% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $90.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 4/24/2024 |
PHM PulteGroup | $113.80 +2.2% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $143.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 4/24/2024 |
TSLA Tesla | $168.29 -1.1% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/24/2024 |
TXN Texas Instruments | $177.48 +1.3% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
UPS United Parcel Service | $147.59 +0.1% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $157.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 4/24/2024 |
V Visa | $274.52 -0.2% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $297.00 -> $299.00 | Low | View details for Oppenheimer rating of Visa (NYSE:V) on 4/24/2024 |
MSCI MSCI | $477.78 +2.9% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/24/2024 |
EA Electronic Arts | $127.90 +0.5% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $150.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 4/23/2024 |
GANX Gain Therapeutics | $3.03 -1.3% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 4/23/2024 |
TTWO Take-Two Interactive Software | $144.47 +0.7% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $185.00 | Low | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/23/2024 |
VZ Verizon Communications | $39.68 +1.2% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/23/2024 |
CHD Church & Dwight | $106.32 -0.9% | 4/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 4/23/2024 |
ATRC AtriCure | $23.17 +2.5% | 4/23/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $32.00 | Low | View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 4/23/2024 |
TARA Protara Therapeutics | $2.93 -3.9% | 4/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 4/22/2024 |
WT WisdomTree | $8.65 -1.4% | 4/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/22/2024 |
KYMR Kymera Therapeutics | $33.37 +0.1% | 4/22/2024 | Initiated by | Oppenheimer | - | Outperform | $53.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 4/22/2024 |
GILD Gilead Sciences | $65.42 +0.2% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 4/19/2024 |
NFLX Netflix | $561.23 -0.6% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 4/19/2024 |
SBUX Starbucks | $88.25 +0.5% | 4/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 4/19/2024 |
BIIB Biogen | $208.90 +3.2% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $290.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/19/2024 |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
EFX Equifax | $223.42 -1.3% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $291.00 -> $272.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/19/2024 |
USB U.S. Bancorp | $41.12 +0.3% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $54.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 4/18/2024 |
XYL Xylem | $132.40 +1.4% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $142.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 4/18/2024 |
SAGE Sage Therapeutics | $13.69 +0.8% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 -> $17.00 | Low | View details for Oppenheimer rating of Sage Therapeutics (NASDAQ:SAGE) on 4/18/2024 |
TRNS Transcat | $109.83 0.0% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $125.00 | Low | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 4/18/2024 |
AOS A. O. Smith | $83.21 +0.5% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 4/18/2024 |
WMS Advanced Drainage Systems | $162.70 +0.8% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $180.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 4/18/2024 |
AVNT Avient | $43.22 +1.0% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $49.00 | Low | View details for Oppenheimer rating of Avient (NYSE:AVNT) on 4/18/2024 |
CSL Carlisle Companies | $400.56 +4.9% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $405.00 -> $412.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/18/2024 |
CARR Carrier Global | $60.50 +1.2% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $63.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/18/2024 |
CAT Caterpillar | $343.38 +1.6% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Caterpillar (NYSE:CAT) on 4/18/2024 |
DOV Dover | $180.17 +0.6% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/18/2024 |
IEX IDEX | $220.66 -1.2% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $252.00 | Low | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 4/18/2024 |
JCI Johnson Controls International | $65.11 +1.0% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $71.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 4/18/2024 |
SPT Sprout Social | $51.39 +0.1% | 4/18/2024 | Initiated by | Oppenheimer | - | Outperform | $76.00 | Low | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 4/18/2024 |
ORCL Oracle | $117.21 +2.0% | 4/18/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 4/18/2024 |
MWA Mueller Water Products | $15.98 -1.1% | 4/18/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 4/18/2024 |
AMRC Ameresco | $21.48 +2.4% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Ameresco (NYSE:AMRC) on 4/17/2024 |
BLZE Backblaze | $9.31 +3.9% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $13.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 4/17/2024 |
BAC Bank of America | $37.83 -0.2% | 4/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $45.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/17/2024 |
FSLR First Solar | $178.73 +2.1% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/17/2024 |
MS Morgan Stanley | $92.83 +0.3% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $101.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/17/2024 |
PANW Palo Alto Networks | $291.42 +0.9% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $305.00 -> $330.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
QMCO Quantum | $0.42 -2.3% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Quantum (NASDAQ:QMCO) on 4/17/2024 |
TWLO Twilio | $60.89 +1.5% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 4/17/2024 |
VIRX Viracta Therapeutics | $0.83 -2.4% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $13.00 | Low | View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/17/2024 |
OBDE Blue Owl Capital Co. III | $15.57 +1.0% | 4/17/2024 | Initiated by | Oppenheimer | - | Outperform | $16.00 | Low | View details for Oppenheimer rating of Blue Owl Capital Co. III (NYSE:OBDE) on 4/17/2024 |
SKIL Skillsoft | $7.25 +6.6% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 4/16/2024 |
AGCO AGCO | $116.61 -0.9% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $154.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/16/2024 |
CNHI CNH Industrial | $11.41 +0.3% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of CNH Industrial (NYSE:CNHI) on 4/16/2024 |
CTVA Corteva | $54.92 +0.4% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $62.00 -> $67.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 4/16/2024 |
GS The Goldman Sachs Group | $427.57 +1.8% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $446.00 -> $479.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/16/2024 |
AVTX Avalo Therapeutics | $15.94 +6.4% | 4/16/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | | Low | View details for Oppenheimer rating of Avalo Therapeutics (NASDAQ:AVTX) on 4/16/2024 |
C Citigroup | $62.66 +1.4% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $87.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/15/2024 |
EL Estée Lauder Companies | $147.45 +1.7% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Estée Lauder Companies (NYSE:EL) on 4/15/2024 |
JPM JPMorgan Chase & Co. | $193.49 +0.1% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $219.00 -> $217.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 4/15/2024 |
VRTX Vertex Pharmaceuticals | $397.48 -0.1% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $500.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/15/2024 |
VERU Veru | $1.27 +5.0% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $5.00 | Low | View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 4/15/2024 |
WFC Wells Fargo & Company | $59.91 0.0% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 4/15/2024 |
ZWS Zurn Elkay Water Solutions | $31.70 -0.6% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $37.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 4/12/2024 |
RVMD Revolution Medicines | $35.96 +1.8% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $45.00 | Low | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 4/12/2024 |
SKYE Skye Bioscience | $13.00 +1.2% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
SKYE Skye Bioscience | $13.00 +1.2% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
QTTB Q32 Bio | $28.02 -0.8% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 4/11/2024 |
LVRO Lavoro | $5.60 -6.4% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $11.00 | Low | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/11/2024 |
XPO XPO | $110.90 -6.2% | 4/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/10/2024 |
KMX CarMax | $69.59 +0.5% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of CarMax (NYSE:KMX) on 4/9/2024 |
CUE Cue Biopharma | $1.37 -2.8% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Cue Biopharma (NASDAQ:CUE) on 4/9/2024 |
EFX Equifax | $223.42 -1.3% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $273.00 -> $291.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/9/2024 |
IONS Ionis Pharmaceuticals | $41.59 -0.6% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $75.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024 |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
MSCI MSCI | $477.78 +2.9% | 4/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $659.00 -> $648.00 | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/9/2024 |
SEIC SEI Investments | $66.57 +0.1% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $77.00 -> $80.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/9/2024 |
TRU TransUnion | $74.49 +0.3% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $90.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/9/2024 |
APP AppLovin | $73.82 +6.7% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $85.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 4/8/2024 |
META Meta Platforms | $443.29 +0.4% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $525.00 -> $585.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/8/2024 |
GOOG Alphabet | $173.69 +10.0% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $185.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/8/2024 |
HCI HCI Group | $115.00 -0.9% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 4/5/2024 |
THG The Hanover Insurance Group | $129.59 -1.3% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 4/5/2024 |
SIGI Selective Insurance Group | $100.13 -1.5% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 | Low | View details for Oppenheimer rating of Selective Insurance Group (NASDAQ:SIGI) on 4/5/2024 |
LULU Lululemon Athletica | $364.70 +1.3% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $540.00 -> $445.00 | Low | View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 4/5/2024 |
TRV Travelers Companies | $213.45 -0.3% | 4/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Travelers Companies (NYSE:TRV) on 4/5/2024 |
AXP American Express | $235.64 -0.6% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 4/5/2024 |
ANGO AngioDynamics | $5.81 +0.5% | 4/5/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of AngioDynamics (NASDAQ:ANGO) on 4/5/2024 |
VRT Vertiv | $93.49 +3.5% | 4/5/2024 | Initiated by | Oppenheimer | - | Outperform | $96.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/5/2024 |
GENI Genius Sports | $5.19 +0.4% | 4/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 4/4/2024 |
ULTA Ulta Beauty | $406.39 -0.4% | 4/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $500.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 4/4/2024 |
COIN Coinbase Global | $236.32 +5.7% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $276.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 4/4/2024 |
AYI Acuity Brands | $252.16 +0.2% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $315.00 | Low | View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 4/4/2024 |
BMEA Biomea Fusion | $10.78 +3.0% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 4/3/2024 |
CMCSA Comcast | $38.57 +1.8% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 | Low | View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/3/2024 |
STRO Sutro Biopharma | $3.42
| 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024 |
TMUS T-Mobile US | $163.96 -0.1% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $190.00 | Low | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 4/3/2024 |
VZ Verizon Communications | $39.68 +1.2% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/3/2024 |
ALDX Aldeyra Therapeutics | $3.93 -0.3% | 4/3/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/3/2024 |
AIT Applied Industrial Technologies | $180.89 +1.1% | 4/2/2024 | Initiated by | Oppenheimer | - | Outperform | $235.00 | Low | View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 4/2/2024 |
MVST Microvast | $0.41 +5.1% | 4/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $4.00 | Low | View details for Oppenheimer rating of Microvast (NASDAQ:MVST) on 4/2/2024 |
MCO Moody's | $376.13 +0.3% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $411.00 -> $424.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 4/2/2024 |
SPGI S&P Global | $415.78 +0.1% | 4/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $480.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/2/2024 |
TSLA Tesla | $168.29 -1.1% | 4/2/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/2/2024 |
JEF Jefferies Financial Group | $43.56 +0.2% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $52.00 -> $54.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/2/2024 |
ACHV Achieve Life Sciences | $4.61 +0.9% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/1/2024 |
CALC CalciMedica | $5.45 +3.0% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 | Low | View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 4/1/2024 |
CTAS Cintas | $666.23 +0.1% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cintas (NASDAQ:CTAS) on 4/1/2024 |
DRRX DURECT | $0.93 +2.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.00 | Low | View details for Oppenheimer rating of DURECT (NASDAQ:DRRX) on 4/1/2024 |
KALA KALA BIO | $6.30 +1.9% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 4/1/2024 |
CATX Perspective Therapeutics | 1.58 -1.3% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 -> 1.50 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 4/1/2024 |
RH RH | $248.91 +2.3% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of RH (NYSE:RH) on 4/1/2024 |
SMTC Semtech | $35.77 +3.1% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Semtech (NASDAQ:SMTC) on 4/1/2024 |
ZURA Zura Bio | $4.41 +21.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $16.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 4/1/2024 |
SG Sweetgreen | $24.52 +7.7% | 4/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $34.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 4/1/2024 |
BRZE Braze | $41.71 +1.3% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 3/28/2024 |
CLRB Cellectar Biosciences | $3.03 +0.3% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 3/28/2024 |
POOL Pool | $371.17 +0.3% | 3/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $407.00 -> $436.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 3/28/2024 |
RUM Rumble | $6.53 -0.2% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Rumble (NASDAQ:RUM) on 3/28/2024 |
SPXC SPX Technologies | $121.52 +1.4% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $124.00 -> $134.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 3/28/2024 |
CXM Sprinklr | $11.93 +0.8% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
VRNT Verint Systems | $30.93 +2.4% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Verint Systems (NASDAQ:VRNT) on 3/28/2024 |
IMVT Immunovant | $27.17 -2.1% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 3/28/2024 |
XERS Xeris Biopharma | $1.75 +2.9% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $5.00 | Low | View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 3/28/2024 |
CPRX Catalyst Pharmaceuticals | $14.89 +1.4% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 | Low | View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/27/2024 |
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad) This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate…
And a cumulative gain of 1729%.
How does it all work? Click Here To Get Your Free Copy |
CGTX Cognition Therapeutics | $1.95 +1.0% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2024 |
FRGE Forge Global | $1.92 +0.5% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $3.50 | Low | View details for Oppenheimer rating of Forge Global (NYSE:FRGE) on 3/27/2024 |
PRGS Progress Software | $50.34 -0.7% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $66.00 | Low | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 3/27/2024 |
STRO Sutro Biopharma | $3.42
| 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 3/27/2024 |
WPRT Westport Fuel Systems | $5.69 +0.9% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
ADBE Adobe | $477.56 +0.9% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/27/2024 |
UPS United Parcel Service | $147.59 +0.1% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $153.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 3/27/2024 |
HCI HCI Group | $115.00 -0.9% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 3/27/2024 |
VKTX Viking Therapeutics | $74.31 +7.9% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $116.00 -> $138.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
ALSN Allison Transmission | $74.49 -7.2% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 3/26/2024 |
A Agilent Technologies | $137.74 +1.0% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Agilent Technologies (NYSE:A) on 3/26/2024 |
ADUS Addus HomeCare | $94.54 +3.1% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 3/26/2024 |
DYN Dyne Therapeutics | $24.73 +4.4% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/26/2024 |
TH Target Hospitality | $11.12 +0.4% | 3/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 3/25/2024 |
TSLA Tesla | $168.29 -1.1% | 3/25/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/25/2024 |
AMPX Amprius Technologies | $1.74 +8.1% | 3/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/22/2024 |
DRI Darden Restaurants | $156.10 -0.3% | 3/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $186.00 -> $182.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
FDS FactSet Research Systems | $421.47 +0.7% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FactSet Research Systems (NYSE:FDS) on 3/22/2024 |
FDX FedEx | $265.84 +0.1% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/22/2024 |
SHAK Shake Shack | $104.88 +3.5% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $108.00 -> $120.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 3/22/2024 |
ROP Roper Technologies | $526.78 -2.5% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 3/22/2024 |
KNF Knife River | $78.25 +0.8% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 3/22/2024 |
DMAC DiaMedica Therapeutics | $2.57 +1.6% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $6.00 | Low | View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/21/2024 |
TKR Timken | $84.98 +0.2% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $100.00 | Low | View details for Oppenheimer rating of Timken (NYSE:TKR) on 3/21/2024 |
TOL Toll Brothers | $120.22 +2.4% | 3/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $141.00 -> $157.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 3/21/2024 |
TRVI Trevi Therapeutics | $2.78 +9.4% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/21/2024 |
VOR Vor Biopharma | $1.69 -0.6% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $15.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
DKS DICK'S Sporting Goods | $207.12 +1.4% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $240.00 | Low | View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 3/20/2024 |
CSL Carlisle Companies | $400.56 +4.9% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $355.00 -> $405.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 3/20/2024 |
CRNX Crinetics Pharmaceuticals | $42.12 -0.4% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $55.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024 |
EQIX Equinix | $731.61 -0.9% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $875.00 -> $950.00 | Low | View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 3/20/2024 |
NVDA NVIDIA | $877.35 +6.2% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $850.00 -> $1,100.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 3/20/2024 |
CRVS Corvus Pharmaceuticals | $1.45 -2.0% | 3/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/20/2024 |
STEP StepStone Group | $36.45 +2.2% | 3/20/2024 | Initiated by | Oppenheimer | - | Outperform | $48.00 | Low | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 3/20/2024 |
GRWG GrowGeneration | $2.22 +0.9% | 3/20/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of GrowGeneration (NASDAQ:GRWG) on 3/20/2024 |
C Citigroup | $62.66 +1.4% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $88.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 3/19/2024 |
CATX Perspective Therapeutics | 1.58 -1.3% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 3/19/2024 |
GS The Goldman Sachs Group | $427.57 +1.8% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $506.00 -> $446.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2024 |
JPM JPMorgan Chase & Co. | $193.49 +0.1% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $238.00 -> $219.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 3/19/2024 |
MS Morgan Stanley | $92.83 +0.3% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $109.00 -> $97.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 3/19/2024 |
USB U.S. Bancorp | $41.12 +0.3% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $55.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 3/19/2024 |
WFC Wells Fargo & Company | $59.91 0.0% | 3/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 3/19/2024 |
ALPN Alpine Immune Sciences | $64.56 -0.1% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $44.00 | Low | View details for Oppenheimer rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
BAC Bank of America | $37.83 -0.2% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 3/19/2024 |
MOD Modine Manufacturing | $96.74 +4.2% | 3/19/2024 | Initiated by | Oppenheimer | - | Outperform | $105.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 3/19/2024 |
CRBP Corbus Pharmaceuticals | $34.25 +2.2% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $51.00 -> $58.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $42.12 -0.4% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $54.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
DRI Darden Restaurants | $156.10 -0.3% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $186.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/13/2024 |
RRX Regal Rexnord | $164.11 +1.3% | 3/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $210.00 | Low | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 3/13/2024 |
TRMB Trimble | $60.15 +1.6% | 3/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 3/14/2024 |
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad) This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate…
And a cumulative gain of 1729%.
How does it all work? Click Here To Get Your Free Copy |
ADBE Adobe | $477.56 +0.9% | 3/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | N/A | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
LEN Lennar | $154.29 +1.0% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Lennar (NYSE:LEN) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $193.33 -0.5% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $320.00 -> $375.00 | N/A | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
PTMN Portman Ridge Finance | $19.55 +0.8% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $20.00 | N/A | View details for Oppenheimer rating of Portman Ridge Finance (NASDAQ:PTMN) on 3/15/2024 |
SEIC SEI Investments | $66.57 +0.1% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $77.00 | N/A | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 3/15/2024 |
SMAR Smartsheet | $38.28 +0.5% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $55.00 | N/A | View details for Oppenheimer rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
URGN UroGen Pharma | $14.15 +2.4% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $34.00 | N/A | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 3/15/2024 |
WSM Williams-Sonoma | $282.16 +0.2% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Williams-Sonoma (NYSE:WSM) on 3/15/2024 |
EW Edwards Lifesciences | $86.43 -1.8% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $100.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 3/18/2024 |
WCN Waste Connections | $163.48 -1.0% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $180.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 3/18/2024 |
VTYX Ventyx Biosciences | $3.93 -3.2% | 3/12/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 3/12/2024 |
NFLX Netflix | $561.23 -0.6% | 3/11/2024 | Target Raised by | Oppenheimer | - | Outperform | $615.00 -> $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 3/11/2024 |
RWAY Runway Growth Finance | $12.78 +1.8% | 3/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
FIGS FIGS | $4.92 +2.3% | 3/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of FIGS (NYSE:FIGS) on 3/8/2024 |
FROG JFrog | $41.99 +3.8% | 3/7/2024 | Target Raised by | Oppenheimer | - | | $41.00 -> $48.00 | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EHAB Enhabit | $10.03 +1.6% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Enhabit (NYSE:EHAB) on 3/7/2024 |
JSPR Jasper Therapeutics | $20.40 -3.7% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 | Low | View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/7/2024 |
MRNS Marinus Pharmaceuticals | $1.41 -0.7% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $9.00 | Low | View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/7/2024 |
PNR Pentair | $79.96 +1.0% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $88.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 3/7/2024 |
RSI Rush Street Interactive | $6.06 +1.8% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $9.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 3/7/2024 |
WCC WESCO International | $155.80 -1.0% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $190.00 | N/A | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 3/7/2024 |
AOMR Angel Oak Mortgage REIT | $10.89 +2.1% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 3/6/2024 |
CNNE Cannae | $19.99 +0.9% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/6/2024 |
CHPT ChargePoint | $1.27 +0.8% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 3/6/2024 |
BASE Couchbase | $25.47 +7.9% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $36.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $304.07 +2.0% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $355.00 | N/A | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
DG Dollar General | $142.07 -0.4% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 3/6/2024 |
HCP HashiCorp | $32.59 -0.7% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $34.00 | Low | View details for Oppenheimer rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
IONS Ionis Pharmaceuticals | $41.59 -0.6% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 3/6/2024 |
MCRB Seres Therapeutics | $0.83 +10.7% | 3/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $5.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
SCM Stellus Capital Investment | $14.14 +1.1% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $14.00 | Low | View details for Oppenheimer rating of Stellus Capital Investment (NYSE:SCM) on 3/6/2024 |
SYF Synchrony Financial | $44.67 +0.0% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Synchrony Financial (NYSE:SYF) on 3/6/2024 |
AEVA Aeva Technologies | $3.09 +5.1% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Aeva Technologies (NYSE:AEVA) on 3/6/2024 |
TCPC BlackRock TCP Capital | $10.09 +1.6% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | $13.00 -> $11.00 | N/A | View details for Oppenheimer rating of BlackRock TCP Capital (NASDAQ:TCPC) on 3/6/2024 |
ETNB 89bio | $8.26 +0.1% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of 89bio (NASDAQ:ETNB) on 3/5/2024 |
CODI Compass Diversified | $22.62 +1.3% | 3/5/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $21.00 -> $23.00 | Low | View details for Oppenheimer rating of Compass Diversified (NYSE:CODI) on 3/5/2024 |
COST Costco Wholesale | $729.18 +1.0% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $760.00 -> $805.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 3/5/2024 |
DYN Dyne Therapeutics | $24.73 +4.4% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/5/2024 |
GE General Electric | $162.35 +0.7% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of General Electric (NYSE:GE) on 3/5/2024 |
IMRX Immuneering | $1.47 +2.8% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 3/5/2024 |
GWW W.W. Grainger | $929.26 -2.0% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,075.00 -> $1,125.00 | Low | View details for Oppenheimer rating of W.W. Grainger (NYSE:GWW) on 3/5/2024 |
AVDL Avadel Pharmaceuticals | $17.81 -0.1% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $27.00 -> $29.00 | Low | View details for Oppenheimer rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/5/2024 |
DLTR Dollar Tree | $121.74 +0.0% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar Tree (NASDAQ:DLTR) on 3/4/2024 |
CYTK Cytokinetics | $65.34 +0.8% | 3/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $107.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 3/4/2024 |
LOW Lowe's Companies | $229.87 0.0% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $230.00 | Low | View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 3/4/2024 |
MDGL Madrigal Pharmaceuticals | $193.33 -0.5% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $320.00 | Low | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/1/2024 |
SG Sweetgreen | $24.52 +7.7% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $17.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 3/1/2024 |
PNTG The Pennant Group | $20.78 +2.3% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $22.00 | Low | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 3/1/2024 |
ADSK Autodesk | $217.93 +0.7% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $265.00 -> $315.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 3/1/2024 |
AVGO Broadcom | $1,344.07 +3.8% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,100.00 -> $1,500.00 | Low | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 3/1/2024 |
ESTC Elastic | $107.43 +2.5% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $130.00 | Low | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 3/1/2024 |
HRZN Horizon Technology Finance | $11.64 +1.0% | 3/1/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Horizon Technology Finance (NASDAQ:HRZN) on 3/1/2024 |
EVH Evolent Health | $27.65 -2.4% | 3/1/2024 | Initiated by | Oppenheimer | - | Outperform | $45.00 | N/A | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 3/1/2024 |
TBLA Taboola.com | $4.23 +0.7% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Taboola.com (NASDAQ:TBLA) on 2/29/2024 |
CHE Chemed | $560.42 -2.3% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $650.00 | Low | View details for Oppenheimer rating of Chemed (NYSE:CHE) on 2/29/2024 |
CRNX Crinetics Pharmaceuticals | $42.12 -0.4% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $48.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/29/2024 |
IMCR Immunocore | $58.46 +0.8% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $87.00 | Low | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 2/29/2024 |
MRVL Marvell Technology | $69.62 +3.2% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $80.00 | Low | View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 2/29/2024 |
MMSI Merit Medical Systems | $73.78 +0.5% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $87.00 | Low | View details for Oppenheimer rating of Merit Medical Systems (NASDAQ:MMSI) on 2/29/2024 |
OKTA Okta | $92.29 -0.7% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $125.00 | Low | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 2/29/2024 |